WASHINGTON, July 31, 2016 /PRNewswire/ -- Today Imalogix announced that radiology leader and clinical researcher Ehsan Samei, PhD, DABR, FAAPM, FSPIE has been named to join its Clinical Advisory Board.
Samei is a tenured Professor of Radiology, Medical Physics, Biomedical Engineering, Physics, and Electrical and Computer Engineering at Duke University, where he also serves as the director of Carl E. Ravin Advanced Imaging Laboratories. He was the founding Director of the Clinical Imaging Physics Group, the Graduate Studies of the Duke Medical Physics Graduate Program, and the co-founder of the Society of Directors of Academic Medical Physics Programs (SDAMPP).
His expertise includes x-ray imaging, theoretical imaging models, simulation methods, and experimental techniques in medical image formation, analysis, assessment, display and perception. The focus of his current research includes methods to develop image quality and dose metrics that can be used to design and utilize advanced imaging techniques towards precise interpretive and quantitative performance.
"We look for outstanding individuals to strengthen our existing clinical advisory board's breadth of clinical and industry expertise and we are thrilled to have Dr. Ehsan Samei join us in this capacity," said John Heil, CEO of Imalogix. "I am confident that he will make many important contributions to Imalogix to further enhance our existing solution."
"I am delighted to join the Imalogix clinical advisory board and be part of a company that is a strong innovative leader in the imaging community for dose and performance management. I am looking forward to the opportunity to contributing to its continued success," said Samei.
Samei has been the recipient of 29 extramural grants from the US government, private foundation and medical industry, and has over 750 scientific publications including 200 referred journal articles.
Further information is available at booth #5086 at AAPM, or visit www.imalogix.com.
About medInt Holdings, LLC d.b.a. ImalogixHeadquartered in King of Prussia, Pa., medInt Holdings, LLC is a Healthcare IT company that integrates with the diagnostic and therapeutic disciplines, turning data into usable knowledge to improve patient safety, increase quality and save lives. Its flagship product, Imalogix™, helps you manage your risk by providing the industry's only enterprise platform to protect your imaging business, your patients, your providers and your margins. For more information, please visit www.imalogix.com.
Advertisement
Samei is a tenured Professor of Radiology, Medical Physics, Biomedical Engineering, Physics, and Electrical and Computer Engineering at Duke University, where he also serves as the director of Carl E. Ravin Advanced Imaging Laboratories. He was the founding Director of the Clinical Imaging Physics Group, the Graduate Studies of the Duke Medical Physics Graduate Program, and the co-founder of the Society of Directors of Academic Medical Physics Programs (SDAMPP).
Advertisement
His expertise includes x-ray imaging, theoretical imaging models, simulation methods, and experimental techniques in medical image formation, analysis, assessment, display and perception. The focus of his current research includes methods to develop image quality and dose metrics that can be used to design and utilize advanced imaging techniques towards precise interpretive and quantitative performance.
"We look for outstanding individuals to strengthen our existing clinical advisory board's breadth of clinical and industry expertise and we are thrilled to have Dr. Ehsan Samei join us in this capacity," said John Heil, CEO of Imalogix. "I am confident that he will make many important contributions to Imalogix to further enhance our existing solution."
"I am delighted to join the Imalogix clinical advisory board and be part of a company that is a strong innovative leader in the imaging community for dose and performance management. I am looking forward to the opportunity to contributing to its continued success," said Samei.
Samei has been the recipient of 29 extramural grants from the US government, private foundation and medical industry, and has over 750 scientific publications including 200 referred journal articles.
Further information is available at booth #5086 at AAPM, or visit www.imalogix.com.
About medInt Holdings, LLC d.b.a. ImalogixHeadquartered in King of Prussia, Pa., medInt Holdings, LLC is a Healthcare IT company that integrates with the diagnostic and therapeutic disciplines, turning data into usable knowledge to improve patient safety, increase quality and save lives. Its flagship product, Imalogix™, helps you manage your risk by providing the industry's only enterprise platform to protect your imaging business, your patients, your providers and your margins. For more information, please visit www.imalogix.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/imalogix-names-ehsan-samei-to-clinical-advisory-board-300306482.html
SOURCE Imalogix
